Cambridge, MA, United States of America

Bakary-Barry Touré

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):

Title: Bakary-Barry Touré: Innovator in FGFR Inhibitors

Introduction

Bakary-Barry Touré is a prominent inventor based in Cambridge, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of FGFR inhibitors. His innovative work has the potential to impact the treatment of various disorders associated with FGFR signaling.

Latest Patents

Touré holds a patent for "FGFR inhibitors and methods of use thereof." This patent relates to novel compounds and pharmaceutical compositions designed to inhibit the activity of FGFR enzymes. The methods outlined in the patent aim to treat disorders linked to FGFR signaling, showcasing the therapeutic potential of his discoveries. He has 1 patent to his name.

Career Highlights

Throughout his career, Touré has worked with notable companies in the biotechnology sector. He has been associated with Relay Therapeutics, Inc. and D.E. Shaw Research, LLC, where he has contributed to groundbreaking research and development efforts.

Collaborations

Touré has collaborated with esteemed colleagues, including Heike Schoenherr and Fabrizio Giordanetto. These partnerships have further enhanced his research and innovation in the field.

Conclusion

Bakary-Barry Touré is a distinguished inventor whose work on FGFR inhibitors holds promise for advancing medical treatments. His contributions to the pharmaceutical industry reflect his commitment to innovation and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…